Showing results (3941-3950 of 11,108) with videos related to
Sort By:
Pageof 1,111
Journal of the National Cancer Institute|January 12, 2012
Targeted therapies for renal cell carcinoma: review of adverse event management strategiesTim Eisen, Cora N Sternberg, Caroline Robert, et al.Journal of the National Cancer Institute|December 14, 2011
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survivalChantal Quinten, John Maringwa, Carolyn C Gotay, et al.Journal of the National Cancer Institute|January 10, 2012
InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markersFreddy Sitas, Sam Egger, Margaret I Urban, et al.Journal of the National Cancer Institute|July 1, 1979
Induction of B-tropic and N-tropic murine leukemia virus from B10.BR/SgLi mouse embryo cell lines by 5-iodo-2'-deoxyuridineB Moll, J W Hartley, W P RoweJournal of the National Cancer Institute|July 1, 1979
Inhibitory effects of butylated hydroxyanisole on methylazoxymethanol acetate-induced neoplasia of the large intestine and on nicotinamide adenine dinucleotide-dependent alcohol dehydrogenase activity in miceL W Wattenberg, V L SparninsJournal of the National Cancer Institute|November 7, 1990
Race, nutritional status, and survival from breast cancerR J Coates, W S Clark, J W Eley, et al.Journal of the National Cancer Institute|November 7, 1990
Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patientsM Pollak, J Costantino, C Polychronakos, et al.Journal of the National Cancer Institute|November 7, 1990
Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II studyJ Treat, A Greenspan, D Forst, et al.Journal of the National Cancer Institute|November 7, 1990
Oral zidovudine, continuous-infusion fluorouracil, and oral leucovorin calcium: a phase I studyM R Posner, J W Darnowski, P Calabresi, et al.Journal of the National Cancer Institute|November 21, 1990
Validation of intermediate end points in cancer researchA Schatzkin, L S Freedman, M H Schiffman, et al.Pageof 1,111